Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
November 19, 2021
Study shows empagliflozin led to a consistent, significant relative risk reduction compared with placebo in the primary endpoint.
COVID-19 can cause atypical thyroid inflammation
March 24, 2021
Patients with thyroid abnormalities during acute COVID-19, or who develop such symptoms, should have thyroid function checked every 6 months for a year.
Inpatient sodium imbalances linked to adverse COVID-19 outcomes
March 11, 2021
Hypernatremia during hospitalization was associated with increased COVID-19 mortality and to a greater need for ventilatory support.
New eGFR equation ‘less biased’ by age, kidney function; some disagree
November 10, 2020
The European Kidney Function Consortium equation surpasses existing equations by "resulting in generally lower bias across the spectrum of age and kidney function," according to its developers.
No link shown between thyroid dysfunction and heart failure
November 10, 2020
Analysis of nearly 5,000 English heart failure patients showed no significant link between thyroid dysfunction and survival.
First-of-its kind guideline on lipid monitoring in endocrine diseases
November 6, 2020
A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond diabetes; the aim is to make lipid panel routine in assessment.
Evidence mounts for COVID-19 effects on thyroid gland
August 19, 2020
Among severely ill patients with COVID-19, rates of thyrotoxicosis are significantly higher than among patients without it. But those with thyroid disorders are not at increased risk of contracting SARS-CoV-2.
Cushing’s and COVID-19: Nontraditional symptoms keys to assessment, treatments
July 2, 2020
Features of Cushing’s syndrome may confound diagnosis and treatment of COVID-19, and also could make patients more susceptible to the pandemic.
COVID-19 may cause subacute thyroiditis
May 21, 2020
This is the first known case of subacute thyroiditis being associated with SARS-CoV-2 infection, according to the authors.
Findings confirm link between methimazole and risk for acute pancreatitis
November 21, 2019
CHICAGO – However, there is no evidence of a cumulative dose effect.